Long-term foscarnet therapy not associat
โ
Gilda Tachedjian; Jenny Hoy; Kate McGavin; Chris Birch
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 496 KB
Sequential human-immunodeficiency virus type 1 (HIV-1) isolates from an acquired immunodeficiency syndrome (AIDS) patient on long-term foscarnet and zidovudine therapy were examined for the emergence of foscarnet resistance. One isolate obtained before therapy, and three postfoscarnet therapy HIV is